The patient with atrial fibrillation undergoing percutaneous angioplasty: triple therapy or new therapeutic strategies?
The management of antithrombotic therapy in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) is a challenge cardiologists face daily. The main difficulty is represented by finding the right balance between the prevention of thrombotic risk and the inevitabl...
Main Authors: | Gianluca Campo, Giulia Bugani |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2018-09-01
|
Series: | AboutOpen |
Subjects: | |
Online Access: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/146 |
Similar Items
-
Dual therapy in a patient with atrial fibrillation at high risk of bleeding
by: Andrea Rolandi
Published: (2018-09-01) -
Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Goto, Koji
Published: (2015) -
Modern strategy of antithrombotic therapy in patients with coronary artery disease and atrial fibrillation after percutaneous coronary intervention
by: Yu. A. Karpov
Published: (2019-12-01) -
Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
by: Gwang-Seok Yoon, et al.
Published: (2021-07-01) -
Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention – real life assessment
by: Paweł Bogacki, et al.
Published: (2016-11-01)